Katalyze AI, an agentic operating system for pharmaceutical companies, raised a $10.5 million seed round, CEO Reza Farahani tells Axios exclusively.
The big picture: Investors are increasingly backing companies that automate the management of pharma bottlenecks, as patent cliffs drive demand for faster development and manufacturing.
